Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,255 | 859 | 99.8% |
| Education | $21.48 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,400 | 92 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,256 | 33 | $0 (2024) |
| Lilly USA, LLC | $1,082 | 109 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $845.55 | 81 | $0 (2024) |
| PFIZER INC. | $749.42 | 83 | $0 (2024) |
| GlaxoSmithKline, LLC. | $615.34 | 97 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $574.12 | 46 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $538.26 | 39 | $0 (2022) |
| Novo Nordisk Inc | $478.95 | 41 | $0 (2024) |
| Astellas Pharma US Inc | $425.43 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,329 | 78 | Amgen Inc. ($243.87) |
| 2023 | $1,451 | 99 | Amgen Inc. ($261.46) |
| 2022 | $1,370 | 107 | Abbott Laboratories ($196.17) |
| 2021 | $731.47 | 61 | Novo Nordisk Inc ($150.75) |
| 2020 | $965.76 | 52 | AstraZeneca Pharmaceuticals LP ($181.69) |
| 2019 | $1,685 | 157 | Amgen Inc. ($210.30) |
| 2018 | $1,704 | 156 | AstraZeneca Pharmaceuticals LP ($243.73) |
| 2017 | $2,042 | 153 | SANOFI-AVENTIS U.S. LLC ($299.77) |
All Payment Transactions
863 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Bone Health | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Bone Health | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: DIABETES | ||||||
| 10/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $66.64 | General |
| Category: Bone Health | ||||||
| 10/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Bone Health | ||||||
| 09/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: DIABETES | ||||||
| 09/23/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.14 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Bone Health | ||||||
| 08/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,643 | 5,012 | $641,114 | $168,633 |
| 2022 | 18 | 1,739 | 5,814 | $669,047 | $184,846 |
| 2021 | 19 | 1,715 | 4,970 | $607,716 | $216,002 |
| 2020 | 18 | 1,650 | 5,129 | $525,670 | $183,707 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 452 | 1,001 | $309,351 | $50,646 | 16.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 26 | 2,220 | $73,260 | $40,508 | 55.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 297 | 620 | $135,356 | $29,150 | 21.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 135 | 139 | $13,886 | $9,975 | 71.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 53 | 150 | $26,199 | $6,754 | 25.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 61 | 112 | $19,638 | $5,720 | 29.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 142 | 146 | $6,416 | $4,459 | 69.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 64 | $11,239 | $3,730 | 33.2% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 15 | 15 | $5,790 | $3,619 | 62.5% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 25 | 25 | $4,925 | $3,212 | 65.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 49 | 86 | $9,054 | $3,187 | 35.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $2,002 | $1,439 | 71.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 26 | 26 | $2,456 | $1,038 | 42.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 18 | 18 | $3,352 | $1,015 | 30.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 91 | $6,076 | $889.44 | 14.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $1,456 | $794.04 | 54.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 15 | $3,570 | $705.98 | 19.8% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 87 | 102 | $2,142 | $492.94 | 23.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 64 | 75 | $1,500 | $459.36 | 30.6% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 29 | 33 | $1,940 | $457.61 | 23.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 21 | $882.00 | $228.40 | 25.9% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 16 | 16 | $624.00 | $154.40 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 493 | 1,110 | $323,778 | $59,009 | 18.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 29 | 2,880 | $86,400 | $49,008 | 56.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 315 | 630 | $129,833 | $28,947 | 22.3% |
About Dr. Bruce Olin, MD
Dr. Bruce Olin, MD is a Internal Medicine healthcare provider based in Dickinson, North Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134116775.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Olin, MD has received a total of $11,277 in payments from pharmaceutical and medical device companies, with $1,329 received in 2024. These payments were reported across 863 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($11,255).
As a Medicare-enrolled provider, Olin has provided services to 6,747 Medicare beneficiaries, totaling 20,925 services with total Medicare billing of $753,187. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Dickinson, ND
- Active Since 09/29/2005
- Last Updated 11/19/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134116775
Products in Payments
- FARXIGA (Drug) $1,082
- ELIQUIS (Drug) $543.49
- ENTRESTO (Drug) $498.96
- JARDIANCE (Drug) $496.60
- EVENITY (Biological) $479.29
- REXULTI (Drug) $416.13
- TRULICITY (Drug) $409.38
- MOUNJARO (Drug) $383.74
- XARELTO (Drug) $271.96
- Otezla (Drug) $269.57
- TOUJEO (Drug) $258.13
- Prolia (Biological) $257.72
- Trintellix (Drug) $254.82
- VRAYLAR (Drug) $239.95
- MYRBETRIQ (Drug) $237.77
- Ozempic (Drug) $221.95
- Repatha (Biological) $199.85
- FREESTYLE LIBRE 2 (Device) $196.17
- TRADJENTA (Drug) $195.45
- Aimovig (Biological) $193.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dickinson
Dr. Nehme Alkarra, Md, MD
Internal Medicine — Payments: $20,461
Leonardo Salazar, Md, MD
Internal Medicine — Payments: $1,101
Mark Hinrichs, Md, MD
Internal Medicine — Payments: $1,063
Patricia Anderson, Md, MD
Internal Medicine — Payments: $489.36
Sridevi Pavuluri, Md, MD
Internal Medicine — Payments: $439.27
Vipulkumar Patel, M. D, M. D
Internal Medicine — Payments: $216.78